Cognition Therapeutics Inc (CGTX)
1.98
+0.04
(+2.06%)
USD |
NASDAQ |
May 17, 16:00
1.98
0.00 (0.00%)
After-Hours: 20:00
Cognition Therapeutics Shareholders Equity (Quarterly): 28.86M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 28.86M |
| December 31, 2023 | 24.47M |
| September 30, 2023 | 28.93M |
| June 30, 2023 | 34.39M |
| March 31, 2023 | 35.78M |
| December 31, 2022 | 40.25M |
| September 30, 2022 | 39.32M |
| Date | Value |
|---|---|
| June 30, 2022 | 43.90M |
| March 31, 2022 | 48.74M |
| December 31, 2021 | 51.27M |
| September 30, 2021 | -86.72M |
| June 30, 2021 | -83.68M |
| March 31, 2021 | -67.85M |
| December 31, 2020 | -68.18M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-86.72M
Minimum
Sep 2021
51.27M
Maximum
Dec 2021
4.962M
Average
31.66M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 38.85M |
| Total Liabilities (Quarterly) | 9.991M |